Cynthia Collins
2019
In 2019, Cynthia Collins earned a total compensation of $14.5M as President and Chief Executive Officer at Editas Medicine.
Compensation breakdown
| Non-Equity Incentive Plan | $143,169 |
|---|---|
| Option Awards | $12,436,552 |
| Salary | $909,174 |
| Stock Awards | $915,400 |
| Other | $85,441 |
| Total | $14,489,736 |
Collins received $12.4M in option awards, accounting for 86% of the total pay in 2019.
Collins also received $143.2K in non-equity incentive plan, $909.2K in salary, $915.4K in stock awards and $85.4K in other compensation.
Rankings
In 2019, Cynthia Collins' compensation ranked 363rd out of 13,971 executives tracked by ExecPay. In other words, Collins earned more than 97.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 363 out of 13,971 | 97th |
Division Manufacturing | 129 out of 5,695 | 98th |
Major group Chemicals And Allied Products | 39 out of 2,194 | 98th |
Industry group Drugs | 31 out of 1,880 | 98th |
Industry Biological Products, Except Diagnostic Substances | 6 out of 389 | 99th |
Source: SEC filing on April 28, 2020.
Collins' colleagues
We found six more compensation records of executives who worked with Cynthia Collins at Editas Medicine in 2019.
2019
Judith Abrams
Editas Medicine
Chief Medical Officer
2019
Charles Albright
Editas Medicine
Chief Scientific Officer
2019
Vic Myer
Editas Medicine
Chief Technology Officer
2019
Eric Ek
Editas Medicine
Chief Financial Officer
2019
Katrine Bosley
Editas Medicine
Chief Executive Officer
2019
Andrew Hack
Editas Medicine